Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Le Pogamp

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Nephrologie|January 1, 1991
[Neurotoxicity of acyclovir in peritoneal dialysis apropos of 1 case]I Guilhem, C Charasse, J Gary, et al.
Pathologie-Biologie|March 1, 1983
Serum angiotensin-converting enzyme levels in patients with chronic renal failureA Le Treut, D Chevet, L Guenet, et al.
Tissue Antigens|November 1, 1980
HLA-DR4 antigen and IgA nephropathyR Fauchet, P Le Pogamp, B Genetet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 1, 1993
Gastrointestinal surgical emergencies following kidney transplantationE Bardaxoglou, G Maddern, L Ruso, et al.
La Revue De Medecine Interne|June 28, 2003
[Epidemiologic description of amyloidosis diagnosed at the University Hospital of Rennes from 1995 to 1999]C Cazalets, B Cador, N Mauduit, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 13, 2001
[Natural history of vascular ports for hemodialysis after renal transplantation]K Bensalah, F Guillé, J Rivalan, et al.
Bulletin De L'Academie Nationale De Medecine|November 1, 1996
["De novo" cancer after organ transplantation]B Launois, B Meunier, C Camus, et al.
British Journal of Cancer|November 25, 2010
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?T Dolley-Hitze, F Jouan, B Martin, et al.
Presse Medicale (Paris, France : 1983)|November 2, 1996
[Economic contribution of mofetil mycofenolate as preventive immunosuppressive treatment after renal transplantation from cadaver]C Louis-Touizer, M J Nuijten, F Bayle, et al.
Transplantation Proceedings|September 19, 2006
Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantationA Al Najjar, I Etienne, P Le Pogamp, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Nephrologie|January 1, 1991
[Neurotoxicity of acyclovir in peritoneal dialysis apropos of 1 case]I Guilhem, C Charasse, J Gary, et al.
Pathologie-Biologie|March 1, 1983
Serum angiotensin-converting enzyme levels in patients with chronic renal failureA Le Treut, D Chevet, L Guenet, et al.
Tissue Antigens|November 1, 1980
HLA-DR4 antigen and IgA nephropathyR Fauchet, P Le Pogamp, B Genetet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 1, 1993
Gastrointestinal surgical emergencies following kidney transplantationE Bardaxoglou, G Maddern, L Ruso, et al.
La Revue De Medecine Interne|June 28, 2003
[Epidemiologic description of amyloidosis diagnosed at the University Hospital of Rennes from 1995 to 1999]C Cazalets, B Cador, N Mauduit, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 13, 2001
[Natural history of vascular ports for hemodialysis after renal transplantation]K Bensalah, F Guillé, J Rivalan, et al.
Bulletin De L'Academie Nationale De Medecine|November 1, 1996
["De novo" cancer after organ transplantation]B Launois, B Meunier, C Camus, et al.
British Journal of Cancer|November 25, 2010
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?T Dolley-Hitze, F Jouan, B Martin, et al.
Presse Medicale (Paris, France : 1983)|November 2, 1996
[Economic contribution of mofetil mycofenolate as preventive immunosuppressive treatment after renal transplantation from cadaver]C Louis-Touizer, M J Nuijten, F Bayle, et al.
Transplantation Proceedings|September 19, 2006
Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantationA Al Najjar, I Etienne, P Le Pogamp, et al.
Pageof 3